Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$104.09 USD

104.09
7,004,290

-0.78 (-0.74%)

Updated May 17, 2024 04:00 PM ET

After-Market: $104.01 -0.08 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 249)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

Abbott (ABT) concluded the recent trading session at $114.02, signifying a +0.08% move from its prior day's close.

Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abbott's (ABT) Innovations Aid, Macroeconomic Issues Stay

by Zacks Equity Research

Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer.

What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?

by Zacks Equity Research

Abbott Laboratories' (ABT) fourth-quarter 2023 results are likely to reflect solid base business momentum.

The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical

by Zacks Equity Research

Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for AMD, Abbott Laboratories & QUALCOMM

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).

Abbott (ABT) Rises Higher Than Market: Key Facts

by Zacks Equity Research

The latest trading day saw Abbott (ABT) settling at $113.92, representing a +0.37% change from its previous close.

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott (ABT) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

Abbott (ABT) closed at $112.73 in the latest trading session, marking a +0.29% move from the prior day.

Tandem Diabetes (TNDM) and Abbott Debut New Integrated Offering

by Zacks Equity Research

Tandem Diabetes' (TNDM) t:slim X2 is the first AID system to be integrated with Abbott's Freestyle Libre 2 Plus sensor.

Derek Lewis headshot

3 Dividend Growers Suited for Income Investors

by Derek Lewis

A company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. Who doesn't enjoy payday?

Here's Why Investors Should Retain Abbott (ABT) Stock Now

by Zacks Equity Research

Investors are optimistic about Abbott (ABT) led by solid prospects in the Diagnostic business and raised guidance.

Moumi Mondal headshot

Wearable Technology Market Gains Ground, 3 Stocks in Focus

by Moumi Mondal

In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.

Abbott (ABT) Stock Moves -0.3%: What You Should Know

by Zacks Equity Research

Abbott (ABT) concluded the recent trading session at $109.52, signifying a -0.3% move from its prior day's close.

Abbott (ABT) Stock Moves -0.2%: What You Should Know

by Zacks Equity Research

The latest trading day saw Abbott (ABT) settling at $109.85, representing a -0.2% change from its previous close.

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Abbott (ABT) Laps the Stock Market: Here's Why

by Zacks Equity Research

In the closing of the recent trading day, Abbott (ABT) stood at $109.79, denoting a +0.51% change from the preceding trading day.

Watch These 5 Stocks That Recently Hiked Dividends

by Zacks Equity Research

Investors may keep a tab on stocks like FULT, SFBS, MOS, ABT and ANDE, which have lately hiked their dividend payments.

PETQ or ABT: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PETQ vs. ABT: Which Stock Is the Better Value Option?

Here's Why Abbott (ABT) Gained But Lagged the Market Today

by Zacks Equity Research

Abbott (ABT) reachead $108.42 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.

Abbott (ABT) Rises Higher Than Market: Key Facts

by Zacks Equity Research

In the closing of the recent trading day, Abbott (ABT) stood at $108.06, denoting a +0.72% change from the preceding trading day.

Abbott (ABT) Gains From Global Expansion Amid Macro Woes

by Zacks Equity Research

Abbott's (ABT) EPD business continues to witness low double-digit growth. It has successfully positioned itself as one of the best-positioned large healthcare companies in emerging markets.

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for NOBL

The Zacks Analyst Blog Highlights JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP

by Zacks Equity Research

JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP are included in this Analyst Blog.